Simponi

BIOLOGICAL2 trials

Sponsors

Chinese University of Hong Kong, Alvotech Swiss AG

Conditions

Ankylosing Spondylitis(AS)Healthy Adult Subjects

Phase 1

A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants

CompletedNCT05632211

Alvotech Swiss AGHealthy Adult Subjects

Start: 2022-12-16End: 2023-10-03Updated: 2025-05-28

Phase 4

Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)

CompletedNCT01212653

Chinese University of Hong KongAnkylosing Spondylitis(AS)

Start: 2010-10-31End: 2013-05-31Updated: 2014-09-11

Related Papers

Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study.

2025-11-10

The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial

Lara D. Veeken2014-02-0556 citations